Filing Details
- Accession Number:
- 0001179110-18-002536
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-21 19:23:17
- Reporting Period:
- 2018-02-16
- Accepted Time:
- 2018-02-21 19:23:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327700 | R Stephen Fussell | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2018-02-16 | 44,909 | $0.00 | 184,884 | No | 4 | A | Direct | |
Common Shares Without Par Value | Acquisiton | 2018-02-20 | 104,642 | $38.40 | 289,526 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 1,100 | $59.47 | 288,426 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 300 | $59.48 | 288,126 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 1,419 | $59.49 | 286,707 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 441 | $59.50 | 286,266 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 1,200 | $59.50 | 285,066 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 1,172 | $59.51 | 283,894 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 200 | $59.52 | 283,694 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 728 | $59.52 | 282,966 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 989 | $59.53 | 281,977 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 226 | $59.54 | 281,751 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 574 | $59.55 | 281,177 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 180 | $59.56 | 280,997 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 500 | $59.58 | 280,497 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 500 | $59.59 | 279,997 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 500 | $59.59 | 279,497 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 100 | $59.60 | 279,397 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 22,500 | $59.60 | 256,897 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 1,600 | $59.63 | 255,297 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 500 | $59.64 | 254,797 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 1,700 | $59.64 | 253,097 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 600 | $59.65 | 252,497 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 4,794 | $59.65 | 247,703 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 3,200 | $59.66 | 244,503 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 10 | $59.66 | 244,493 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 8,206 | $59.66 | 236,287 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 2,985 | $59.67 | 233,302 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 77 | $59.67 | 233,225 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-02-20 | 100 | $59.67 | 233,125 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Acquisiton | 2018-02-16 | 246,963 | $0.00 | 246,963 | $59.94 |
Common Shares | Option (right to buy) | Disposition | 2018-02-20 | 104,642 | $0.00 | 104,642 | $38.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
246,963 | 2019-02-16 | 2028-02-15 | No | 4 | A | Direct |
104,642 | 2018-02-19 | 2026-02-18 | No | 4 | M | Direct |
Footnotes
- These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 82,321 on 02/16/2019, 82,321 on 02/16/2020, and 82,321 on 02/16/2021.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.